HKSE · 1094.HK
Cherish Sunshine International Limited
HK$0.67+HK$0.02 (+2.31%)
Cherish Sunshine International Limited’s quoted price sits in the upper half of its reported 52-week range, 14.74% below the high.
Loading market information…
HKSE · 9600.HK · HKD
Stock price, dividends, earnings
Quote as of Oct 28, 2026, 05:25 AM UTC. Cached market data; not a live quote.
One-year closing-price history · HKD. Historical prices are not a forecast.
Newlink Technology Inc.’s quoted price sits in the lower half of its reported 52-week range, 68.41% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Newlink Technology Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Newlink Technology Inc., an investment holding company based in Beijing, China, focuses on providing solutions leveraging big data analytics and artificial intelligence. Its operations are divided into three main segments: Financial Institutions, Medical Institutions, and Other. The company's offerings include software engineering, technical support, and maintenance services, alongside the sale of proprietary software products. Notably, they provide robotic process automation (RPA) systems, integrated RPA machinery, and intelligent management platforms built upon medical and health big data. Their portfolio also extends to specialized solutions such as medical quality assurance and safety alert platforms, clinical pathway optimization systems, smart healthcare platforms, and remote medical services. Newlink Technology serves a diverse client base, encompassing financial sector entities like banks, trust companies, and asset management firms, as well as healthcare providers such as hospitals, among other customers. The company was founded in 2011.
Latest available per-share figures in HKD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:41 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
HK$0.67+HK$0.02 (+2.31%)
Cherish Sunshine International Limited’s quoted price sits in the upper half of its reported 52-week range, 14.74% below the high.
HK$0.25HK$0.00 (0.0%)
AI X Tech Inc.’s quoted price sits in the lower half of its reported 52-week range, 34.67% below the high.
HK$0.27+HK$0.01 (+1.89%)
Vital Innovations Holdings Limited’s quoted price sits in the upper half of its reported 52-week range, 34.94% below the high.
HK$0.31+HK$0.03 (+10.91%)
Wong's Kong King International (Holdings) Limited’s quoted price sits in the lower half of its reported 52-week range, 72.77% below the high.
HK$5.10-HK$0.06 (-1.16%)
Willas-Array Electronics (Holdings) Limited’s quoted price sits in the lower half of its reported 52-week range, 41.04% below the high.
HK$0.05-HK$0.00 (-1.85%)
Yuxing InfoTech Investment Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 46.46% below the high.
HK$0.15+HK$0.00 (+2.74%)
Brainhole Technology Limited’s quoted price sits in the lower half of its reported 52-week range, 44.44% below the high.
HK$0.18HK$0.00 (0.0%)
Sinopharm Tech Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 49.3% below the high.
